Background for Rosetta Genomics (ROSG)

Posted on April 4th, 2007 by Brian

Basic Info

Stock symbol:ROSG
Website:http://www.rosettagenomics.com/
IPO date: 2/27/07
Total shares outstanding: 11.8 million
Market Cap: $77.5 million as of 4/4/07
Other reviews: History of attempts at Rosetta Genomics’ IPO and some background info
If you know of others please add them in the comments.

Drugs/Platforms

Diagnostics:
Cancer of Unknown Primary (CUP) diagnostic test using miRNAs
Prostate cancer diagnostic test using miRNAs (with Asuragen)

Drugs in development:
Drugs that regulate miRNAs in liver cancer (with Isis Pharmaceuticals)

Financials

Income: Yeah Right!
Money on hand: $37 million including $26.2 million from the IPO
Burn Rate: about $7.6 million in 2006

Filed under: Rosetta Genomics (ROSG)

« Back to the Basics: The Building Blocks of the Cells (and drugs that affect them) Micro RNAs: The Last Frontier of Medicine? »

4 Responses to “Background for Rosetta Genomics (ROSG)”

  1. story amateur sex, on December 13th, 2007 at 2:03 am Said:

    amateur submitted sex sex amateur father

  2. avenged harlot sevenfold, on February 28th, 2008 at 9:54 am Said:

    myspace avenged sevenfold avenged unholy sevenfold

  3. hentai toe hate, on September 4th, 2008 at 4:14 pm Said:

    hate hentai bite guro hentai hate

  4. Gay Harrell, on November 12th, 2008 at 6:22 pm Said:

    8ucte4tzegfi9pq7

Leave a Reply